Loss of P2XM Gene Expression in Soft-Tissue Tumors
Author Information
Author(s): Nawa G, Miyoshi Y, Yoshikawa H, Ochi T, Nakamura Y
Primary Institution: Osaka University Medical School
Hypothesis
Does the expression of the P2XM gene play a role in soft-tissue tumors?
Conclusion
The study suggests that changes in P2XM expression may be important in the development of both benign and malignant soft-tissue tumors.
Supporting Evidence
- 12 out of 47 sarcomas lost expression of the P2XM gene.
- 22 sarcomas showed altered splicing patterns of P2XM.
- 4 out of 9 benign tumors showed no expression of P2XM.
- 3 benign tumors revealed aberrant splicing patterns of P2XM.
Takeaway
The researchers looked at a gene called P2XM in tumors and found that many tumors had problems with this gene, which might help explain how these tumors grow.
Methodology
The study examined P2XM expression in 56 human primary soft-tissue tumors using reverse transcription polymerase chain reaction.
Participant Demographics
The study included 56 human primary soft-tissue tumors, consisting of 47 sarcomas and 9 benign tumors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website